
Iceni Diagnostics appoints BBI to produce its Covid-19/Influenza test
Iceni Diagnostics has appointed BBI Solutions to produce clinical trial batches for their new, rapid SARS-COV-2/Influenza virus detection test. The test exploits the diagnostic company’s unique, proprietary HPGR™ (Host-Pathogen Glycan Recognition) technology to detect the presence of live virus in non-invasive samples within 15 minutes.